logo

TEVA

Teva Pharmaceutical·NYSE
--
--(--)
--
--(--)

TEVA fundamentals

Teva Pharmaceutical (TEVA) Revenue Breakdown: Q3 2025 Business & Regional Performance
Teva Pharmaceutical (TEVA) reported total revenue of 3.89B USD in Q3 2025, with its core business segment United States contributing 48.24%. Regionally, United States remained the largest market, accounting for 56.10% of total revenue. Explore Teva Pharmaceutical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data